Home >
Medicine Info >
En-Clofert 50 Tablet
Loading interface...

En-Clofert 50 Tablet

Manufactured byMANEESH PHARMACEUTICALS LTD
ContainsEnclomiphene
Description
En-Clofert 50 Tablet is a selective estrogen receptor modulator medicine, which may be used for the treatment of female infertility.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for En-Clofert 50 Tablet

  • Headache
  • Abdominal discomfort
  • Nausea

Uses of En-Clofert 50 Tablet

What is it prescribed for?

  • Female infertility
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to enclomiphene, or any other inactive ingredients present in the formulation.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.
General warnings

Other medicines

This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Suppression of menstruation

This medicine may cause irregular periods in some women. Discuss the risks and benefits with your doctor before taking this medicine.

Missed Dose

Call the doctor for further instructions if you miss a scheduled dose of this medicine.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine exactly as instructed by the doctor. Your dose is likely to change over the course of treatment. It is advised to undergo tests that will ensure the safe and effective use of this medicine. Follow all the instructions mentioned on the label or the package insert.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Effect on sleep is not established

How it works
This medicine stimulates the release of an egg from the ovary in women.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Selective estrogen receptor modulators

Schedule

Schedule H

Enclomiphene - DrugBank [Internet]. Drugbank.ca. 2018 [cited 28 December 2018]. Available from:

https://www.drugbank.ca/drugs/DB06735

Enclomiphene Tablet Manufacturers Suppliers in India - WHO:GMP Third Party Contract Manufacturing [Internet]. Trumac Healthcare. 2020 [cited 11 February 2020]. Available from:

https://www.trumachealthcare.net/enclomiphene-tablet-manufacturers-suppliers-in-india-whogmp-third-party-contract-manufacturing/

Enclomiphene citrate [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 27 February 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Enclomiphene-citrate
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Feb 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.